Synthase squalene

The search for inhibitors of this pathway began with the first key regulatory enzyme, HMG CoA reductase. Several clinically useful inhibitors of HMG CoA reductase are now known. One of the most successful, Mevacor, produced by Merck, is one of the pharmaceutical industry s best selling products. However, the problem with inhibiting a branched biosynthetic pathway at an early point is that the biosynthesis of other crucial biomolecules may also be inhibited. Indeed, there is some evidence that levels of ubiquinone and the dolichols are affected by some HMG CoA reductase inhibitors. Consequently, efforts have recently been directed towards finding inhibitors of squalene synthase, the enzyme controlling the first step on the route to cholesterol after the FPP branch point. 

Medicinal chemistry has frequently drawn inspiration and important new leads from the examination of natural products, and this was proven to be the case once more. In 1992, researchers at Merck and Glaxo announced, almost simultaneously, the independent discovery of the same new class of natural products from two different fungi. As a consequence, the same family of natural products has two names - the zaragozic acids (Merck)4 or the squalestatins (Glaxo).5 A typical member of the family, zaragozic acid A (squa-lestatin SI) (1) was shown to have a tremendous affinity for squalene synthase (K, = 79 pM for rat microsomal squalene synthase) and could even lower serum cholesterol levels in vivo in a population of marmosets.6... 

The first C40 carotenoid, phytoene, is produced by head-to-head condensation of two GGPPs by an enzyme that shares homology to GGPPS and squalene synthases... 

Lee MH et al (2004) Enhanced triterpene and phytosterol biosynthesis in Panax ginseng overexpressing squalene synthase gene. Plant CeU Physiol 45 976... 

NAD(P)H DEHYDROGENASE (QUINONE) NITRIC OXIDE SYNTHASE PHENOL HYDROXYLASE PROTOCHLOROPHYLLIDE REDUCTASE SQUALENE SYNTHASE SULFITE REDUCTASE NADPH diaphorase,... 

SQUALENE SYNTHASE SULFATE ADENYLYLTRANSFERASE UBIQUITIN-PROTEIN LIGASES PYROPHOSPHATE FRUOTOSE-6-PHOS-PHATE 1-PHOSPHOTRANSFERASE PYROPHOSPHOMEVALONATE DECARBOXYLASE... 

Zaragozic acid or the squalastatins were discovered as fungal metabolites and have been identified as potent inhibitors of squalene synthase. These compounds have presented themselves as potential cholesterol lowering agents. 

In Tabernaemontana divaricata treatment of plant cell suspension cultures with an elicitor cause inhibition of CS activity [24,25]. This response is accompanied by stimulation of activity of constitutive enzyme activities of the isoprenoid pathway leading to 2,3-oxidosqualene (squalene synthase and squalene oxidase), and induction of enzymes required for biosynthesis of pentacyclic triterpenoid phytoalexins (/lAS and aAS). Thus inhibition of the branchpoint enzyme CS results in increased flux through the triterpenoid pathway. 

Komine, H., T. Takahashi, and S. Ayabe. 1996. Properties and partial purification of squalene synthase from culture of dandelion. Phytochemistry 42 405-409. 

Scheme 7.6 Stereoselective acetylation of the hydroxyl diethyl ester (9) to the (S)-acetate as an intermediate for the synthesis of a squalene synthase inhibitor ( ) of cholesterol synthesis.

Squalene takes part in metabolism as precursor for synthesis of steroids and structurally quite similar to (3-carotene, coenzyme qlO, vitamins Ki, E, and D. The squalene in skin and fat tissue comes from endogenous cholesterol synthesis as well as dietary resources in people who consume high amounts of olive and fish oil especially shark liver (Gershbein and Singh, 1969). Squalene is synthesized by squalene synthase which converts two units of farnesyl pyrophosphate, direct precursor for terpenes and steroids, into squalene. As a secosteroid, vitamin D biosynthesis is also regulated by squalene. Moreover, being precursor for each steroid family makes squalene a crucial component of the body. 

Fig. 5.1.2 Cholesterol biosynthesis branch of the isoprenoid biosynthetic pathway. Enzymes are numbered as follows 1 squalene synthase 2 squalene epoxidase 3 2,3-oxidosqua-lene sterol cyclase 4 sterol A24-reductase (desmosterolosis) 5 sterol C-14 demethylase 6 sterol A14-reductase (hydrops-ectopic calcification-moth-eaten, HEM, dysplasia) 7 sterol C-4 demethylase complex (including a 3/ -hydroxysteroid dehydrogenase defective in congenital hemidyspla-sia with ichthyosiform nevus and limb defects, CHILD, syndrome) 8 sterol A8-A7 isomerase (Conradi-Hunermann syndrome CDPX2) 9 sterol A5-desaturase (lathosterolosis) 10 sterol A7-reductase (Smith-Lemli-Opitz syndrome). Enzyme deficiencies are indicated by solid bars across the arrows...

One of the best therapeutic approaches may be to prevent absorption of cholesterol from the intestines by inclusion of a higher fiber content in the diet.66 Supplementation with a cholesterol-binding resin may provide additional protection. Plant sterols also interfere with cholesterol absorption. Incorporation of esters of sitostanol into margarine provides an easy method of administration. Supplemental vitamin E may also be of value.q Another effective approach is to decrease the rate of cholesterol synthesis by administration of drugs that inhibit the synthesis of cholesterol. Inhibitors of HMG-CoA reductase,s hh (e.g., vaLostatin) iso-pentenyl-PP isomerase, squalene synthase (e.g.,... 

Zaragozic Acids The zaragozic acids (squalestatins) are a class of competitive inhibitors of mouse, rat, and HepG2 squalene synthases, which also display antifungal activity [104]. The characteristic structural feature of this family of natural products is its highly oxygenated core. 

Bergstrom JD, Dufresne C, Bills GF, Nallin-Omstead M and Byrne K (1995) Discovery, biosynthesis and mechanism of action of the zaragozic acids potent inhibitors of squalene synthase. Annu Rev Microbiol 49, 607-639. 

Watson NS and Procopiou PA (1996) Squalene synthase inhibitors their potential as hypocholesterolaemic agents. Prog Med Chem 33, 331-378. 

Shechter I, Guan G and Boettcher BR (1999) Squalene synthase. Comprehensive Natural Products Chemistry, Vol 2. Elsevier, Amsterdam, pp 245-266. 

Miki, T. Kori, M. Mabuchi, H. Banno, H. Tozawa, R. Nakamura, M. Itokawa, S. Sugiyama, Y. Yukimasa, H. Novel 4,1-benz-oxazepine derivatives with potent squalene synthase inhibitory activities. Bioorg. Med. Chem. 2002, 10, 401 114. 

---